Findings of 18F‐PI‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample

Findings of 18F‐PI‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample

Abstract Background Alzheimer’s disease (AD) is the most common cause of dementia worldwide. In AD, abnormal tau accumulates within neurons of the brain, facilitated by extracellular β‐amyloid deposition, leading to neurodegeneration, and eventually, cognitive impairment. As this process is thought...

Full description

Bibliographic Details
Main Authors: Shogyoku Bun, Sho Moriguchi, Toshiki Tezuka, Yoshiaki Sato, Keisuke Takahata, Morinobu Seki, Shinichiro Nakajima, Yasuharu Yamamoto, Yasunori Sano, Natsumi Suzuki, Ayaka Morimoto, Ryo Ueda, Hajime Tabuchi, Daisuke Ito, Masaru Mimura
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Neuropsychopharmacology Reports
Subjects:
Alzheimer’s disease
MMSE
plasma p‐181
positron emission tomography
tau
tauADAS‐cog
Online Access:https://doi.org/10.1002/npr2.12281

Internet

https://doi.org/10.1002/npr2.12281

Similar Items